AbbVie Inc. (ABBV) is in Healthcare, Drug Manufacturers - General, based in United States, listed on NYSE. Market cap 481.40B USD. 52-week range 190.75 to 274.94 USD. Trailing P/E 77.0. Data as of 2026-10-09.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides ...